Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesAdult-onset Still’s disease, Schnitzler syndrome, and autoinflammatory syndromes in adulthood
Zeitschrift für Rheumatologie, 10/29/09
Lamprecht P – Adult–onset Still’s disease (AoSD), Schnitzler syndrome, and cases of adult–onset autoinflammatory syndromes are characterized by a genetic predisposition, with increased interleukin (IL)–1beta and IL–18 production and TNF–alpha signaling, respectively. Recently published studies have shown that patients with Schnitzler syndrome, methotrexate–refractory AoSD, and colchicine–refractory FMF or contraindications to colchicines in FMF respond well to treatment with the soluble IL–1 receptor antagonist anakinra. For TRAPS patients, the p75 TNF–alpha receptor/Fc–IgG1 fusion protein etanercept is the treatment of first choice.
Related Articles
Clinical significance of 18F-fluoro-dexoxyglucose positron emission tomography in patients with adult-onset Stills disease: report of two cases and review of literatures
Rheumatology International, 10/02/09
Relevance Score: 67%
Adult onset Stills disease diagnosed concomitantly with occult papillary thyroid cancer: paraneoplastic manifestation or coincidence
Clinical Rheumatology, 11/12/09
Relevance Score: 65%
Ground-glass-like hepatocellular inclusions in the course of adult-onset Stills disease
Modern Rheumatology, 10/23/09
Relevance Score: 65%
Adult-onset Still's Disease With Pulmonary Involvement
Journal of Bronchology, 10/19/09
Relevance Score: 65%
Cyclosporine A-induced neck fibrosis in a patient with adult-onset Stills disease
Clinical Rheumatology, 10/12/09
Relevance Score: 65%
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study
Pain Medicine, 12/10/09
Does classification of persons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differences in outcome after a standard chronic pain management program?
Pain Research and Management, 12/10/09
Fibromyalgia: A Distinct Disease
The Female Patient, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor